跳至主要内容
临床试验/NL-OMON32451
NL-OMON32451已完成3 期

The effect of treatment with high dose vitamin D on airway inflammation in non-atopic asthma. - Vitamin D in non-atopic asthma

Medisch Centrum Leeuwarden0 个研究点目标入组 58 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Non-atopic asthma (negative alatop test and pulmonologist's diagnosis of asthma)
  • neutrophilic and/or eosinophilic inflammation in induced sputum (>53% neutrophils and/or >3% eosinophils)
  • Documented reversibility in FEV1 of > 12% predicted OR airway hyperresponsiveness to inhaled methacholine

排除标准

  • Contra-indications regarding vitamin D use: hypercalcaemia, malignancy, sarcoidosis, history of kidneystones.
  • Patients with smoking history of >10 packyears and persistent airflow obstruction (post bronchodilator FEV1<80%pred): excluded if reversibility in FEV1 < 12% predicted OR TLCO<80%pred.
  • Vitamin D use prior to this study.
  • Other pulmonary diseases
  • Vitamin D3 level > 100 nmol/l

研究者

发起方
Medisch Centrum Leeuwarden

相似试验